Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNCOVERED: 9 - The Untold Story

Breakthrough Treatment Veoza Receives UK Approval to Tackle Hot Flushes

Veoza distinguishes itself as a non-hormonal menopause drug that directly targets the brain to prevent hot flushes.

International Business Times UK

A 'game-changing' new drug for hot flushes has just been approved: what does this mean for UK women?

Veoza is the new drug for hot flushes that's been approved for use in the UK with immediate effect

Woman & Home

The era of CRISPR therapeutics is here – what can we expect? | Explained

Two geneticists explain the groundbreaking CRISPR-based therapies approved for sickle-cell disease and β-thalassaemia, and other genetic therapeutics in development, including base-editing and prime-editing.

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Safe Biotech Stocks to Buy This Week

Given enhanced healthcare spending, the growing frequency of chronic diseases, government support, and rapid digital transformation, the biotech industry appears to have favorable prospects. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Acorda Therapeutics, Inc. (ACOR) could be ideal additions to your portfolio this week. Read more….

StockNews.com

The world's 1st CRISPR therapy has just been approved. Here's everything you need to know

U.K. regulators have approved the use of a CRISPR therapy called Casgevy to treat two inherited blood disorders. But what is it and how does it work?

LiveScience

The First CRISPR Gene Therapy Was Finally Approved In The US — Here’s How It Works

Using the gene editing tool CRISPR, the new therapy promises a cure for those with sickle cell anemia and beta thalassemia, but cost could be a barrier to care.

Inverse

Blood disorder breakthrough as world-first gene therapy given green light

The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

World-first gene therapy for inherited blood disorders approved in UK

The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020.

The Independent UK

What is anastrozole? All you need to know about the new breast cancer drug

Anastrozole has the potential to reduce the risk of breast cancer by almost 50% for many postmenopausal women at risk, here's what you need to know

Woman & Home

Diabetes drug authorised for weight management and loss – MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

The Independent UK

Private health firm Sciensus fails to fix defects that led to UK patient’s death

Exclusive: Regulator extends part suspension of licence to July 2024 after IT blunder led to incorrect dosage of cancer treatment

The Guardian - UK

Functional fungi: can medicinal mushrooms really improve people’s health?

The boom in sales of mushroom products has led to many claims for their wellbeing and curative properties, but is there any scientific evidence to back them up?

The Guardian - UK

Urgent warning over counterfeit Ozempic after hospitalisations

Medicines regulator seizes 369 potentially fake devices amid surge in demand

Evening Standard

Warning as patients hospitalised after taking fake Ozempic weight-loss drug

Hundreds of fake Ozempic jabs from the black market have been seied by the regulator

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

UK public warned over dangers of fake weight loss medication pens

Pre-filled injection devices claimed to hold Ozempic or Saxenda may contain other substances, regulator says

The Times of India

Taking cholesterol-reducing pills? Serious side effects you need to know

Last week, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) had released a report stating that "there have been some suspected reports of new-onset or aggravation of pre-existing myasthenia gravis or ocular myasthenia associated with statin use." Myasthenia gravis is an autoimmune neuromuscular disorder that is characterised by fluctuating…

The Guardian - UK

‘These patients do not have time’: families in UK demand access to new drug that slows brain tumours

Vorasidenib worked in trials but is not yet available on the NHS

The Independent UK

‘I didn’t want to be here anymore’: The agony of women suffering with topical steroid withdrawal

The condition is caused after the repeated use of steroid creams and tablets commonly prescribed by the NHS, Holly Evans writes

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Patients in England will be first to access seven-minute cancer treatment jab

NHS is first health system to offer injection to hundreds of patients which will cut treatment times by up to three quarters

The Independent UK

Public bodies named and shamed over Freedom of Information request failings

The Information Commissioner’s Office urged organisations to ensure their performance and processes complied with the law.

The Week

Why life-threatening allergic reactions are on the rise

Hospital admissions for life-threatening allergic reactions have increased from 12,361 in 2002-03 to 25,721 in the past year, latest NHS figures show.

The Independent UK

Men sentenced for selling unauthorised Covid-19 tests during pandemic

Ron Huss-Smickler, 41 from Birmingham, and Steven Lawrence Beckford, 39 from Edgbaston, bought the non-certified coronavirus tests from Alibaba.

The Guardian - UK

Hospital admissions for life-threatening allergies more than double in England

Number of people taken to hospital increased to 25,721 in 2022-23, from 12,361 two decades before

The Independent UK

Hospital admissions for life-threatening allergic reactions ‘more than double’

Data obtained by drugs regulator the MHRA shows there were 25,721 admissions to England’s hospitals for allergies and anaphylaxis in 2022/23.

The Guardian - UK

Weight-loss drugs under review in UK after reports of suicidal thoughts

Ozempic and Saxenda among drugs being reviewed after five reports of suspected adverse reactions in patients

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Environment Agency

655 stories

MHRA

342 stories

Liverpool City Council

Vertex Pharmaceuticals Incorporated

65 stories

Vertex Pharmaceuticals

64 stories

Tower Hamlets Council

39 stories

Allergy UK

26 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.